Louise Bannon: Did You Know That Arterial Thrombosis Is One of The Top Global Killers?
Louise Bannon, Director of Membership, Marketing and External Relations at ISTH, reposted from WHO on LinkedIn:
”Did you know that arterial thrombosis, which can cause heart attack and stroke, is one of the top global killers?
High blood pressure (hypertension) is the leading risk factor for these events.
Venous thrombosis, deep vein thrombosis (DVT) and pulmonary embolism (PE), can also be life-threatening, especially after surgery, periods of immobility, cancer or hormonal therapy.
With 1.4 billion people living with hypertension worldwide (World Health Organization), understanding thrombosis, how it happens, its risk factors and how to prevent it, has never been more important.
Learn the signs. Know your risk. Take action to protect your health.”
World Health Organization (WHO) shared on LinkedIn:
”New WHO report finds 1.4 billion people live with hypertension.
Hypertension is the number one risk factor for:
- Heart attack
- Stroke
and can lead to:
- Chronic kidney disease
- Dementia
Get your blood pressure checked today! Learn more here.”

Stay updated on all advances in the field of thrombosis with Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera
